Search for "dbv"

Dave Bloom - 2017/11/20 0

The trial met its primary objective, demonstrating that Viaskin Peanut was well-tolerated with no new or unexpected adverse events.

Dave Bloom - 2017/10/24 0

The Viaskin Peanut patch therapy still has 50:50 chance of approval according to research note.

Dave Bloom - 2017/03/22 1

The study received higher-than-expected patient demand.

Dave Bloom - 2017/03/07 0

The study model used common packaged foods such as cookies, ice cream, and doughnuts as references.

Dave Bloom - 2017/03/07 0

Pediatric patients responded with a favorable safety profile and no serious adverse effects.

Dave Bloom - 2016/10/25 0

The study was designed to assess the long-term efficacy and safety of the treatment in subjects that had graduated from their earlier VIPES trial.

Dave Bloom - 2016/06/13 0

The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.

Dave Bloom - 2016/03/07 5

We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.

Dave Bloom - 2015/10/28 1

What it means to be a breakthrough therapy, who is developing them, how they work, and the (big) business drivers behind them.

Dave Bloom - 2015/06/30 0

The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.

dbv - search results